Mobia Medical (MOBI) – Investment Analysts’ Weekly Ratings Changes

Mobia Medical (NASDAQ: MOBI) recently received a number of ratings updates from brokerages and research firms:

• 6/6/2026 – Mobia Medical was downgraded by Wall Street Zen from “hold” to “sell”.
• 6/3/2026 – Mobia Medical was upgraded by Zacks Research to “hold”.
• 6/2/2026 – Mobia Medical is now covered by Wolfe Research. They set an “outperform” rating on the stock.
• 6/2/2026 – Mobia Medical is now covered by The Goldman Sachs Group, Inc.. They set a “buy” rating and a $31.00 price target on the stock.
• 6/2/2026 – Mobia Medical is now covered by The Goldman Sachs Group, Inc.. They set a “buy” rating and a $31.00 price target on the stock.
• 6/2/2026 – Mobia Medical is now covered by JPMorgan Chase & Co.. They set an “overweight” rating and a $15.00 price target on the stock.
• 6/2/2026 – Mobia Medical is now covered by BTIG Research. They set a “buy” rating and a $19.00 price target on the stock.
• 6/2/2026 – Mobia Medical is now covered by Bank of America Corporation. They set a “buy” rating and a $16.00 price target on the stock.
• 5/16/2026 – Mobia Medical was upgraded by Wall Street Zen to “hold”.

Insider Activity at Mobia Medical

In other Mobia Medical news, insider Chase C. Leavitt bought 3,000 shares of the stock in a transaction on Monday, May 11th. The stock was purchased at an average price of $15.00 per share, with a total value of $45,000.00. Following the acquisition, the insider owned 3,000 shares of the company’s stock, valued at approximately $45,000. The trade was a ? increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Cynthia L. Lucchese bought 125,000 shares of the stock in a transaction on Monday, May 11th. The shares were acquired at an average cost of $15.00 per share, with a total value of $1,875,000.00. Following the acquisition, the director directly owned 125,000 shares in the company, valued at approximately $1,875,000. This trade represents a ? increase in their position. The disclosure for this purchase is available in the SEC filing. In the last quarter, insiders have acquired 1,268,332 shares of company stock valued at $19,024,980.